AU2024208125A1 - Spiro derivatives as m4 activators/modulators and uses thereof - Google Patents
Spiro derivatives as m4 activators/modulators and uses thereofInfo
- Publication number
- AU2024208125A1 AU2024208125A1 AU2024208125A AU2024208125A AU2024208125A1 AU 2024208125 A1 AU2024208125 A1 AU 2024208125A1 AU 2024208125 A AU2024208125 A AU 2024208125A AU 2024208125 A AU2024208125 A AU 2024208125A AU 2024208125 A1 AU2024208125 A1 AU 2024208125A1
- Authority
- AU
- Australia
- Prior art keywords
- activators
- modulators
- spiro derivatives
- spiro
- derivatives
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems
- C07D491/107—Spiro-condensed systems with only one oxygen atom as ring hetero atom in the oxygen-containing ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/08—Bridged systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Hospice & Palliative Care (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202363479579P | 2023-01-12 | 2023-01-12 | |
| US63/479,579 | 2023-01-12 | ||
| PCT/US2024/011203 WO2024151833A1 (en) | 2023-01-12 | 2024-01-11 | Spiro derivatives as m4 activators/modulators and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2024208125A1 true AU2024208125A1 (en) | 2025-07-10 |
Family
ID=89977492
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2024208125A Pending AU2024208125A1 (en) | 2023-01-12 | 2024-01-11 | Spiro derivatives as m4 activators/modulators and uses thereof |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP4649077A1 (en) |
| KR (1) | KR20250133755A (en) |
| CN (1) | CN120641409A (en) |
| AU (1) | AU2024208125A1 (en) |
| CO (1) | CO2025010728A2 (en) |
| IL (1) | IL321657A (en) |
| MX (1) | MX2025007982A (en) |
| WO (1) | WO2024151833A1 (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2624697B1 (en) | 2010-10-04 | 2015-11-25 | Merck Sharp & Dohme Corp. | Dihydrobenzoquinazolinone m1 receptor positive allosteric modulators |
| UA122121C2 (en) * | 2014-02-06 | 2020-09-25 | Хептерс Терап'Ютікс Лімітед | Bicyclic aza compounds as muscarinic m1 receptor and/or m4 receptor agonists |
| EP4219464A1 (en) * | 2018-03-23 | 2023-08-02 | Pfizer Inc. | Piperazine azaspiro derivaves |
-
2024
- 2024-01-11 AU AU2024208125A patent/AU2024208125A1/en active Pending
- 2024-01-11 EP EP24705876.1A patent/EP4649077A1/en active Pending
- 2024-01-11 CN CN202480010033.6A patent/CN120641409A/en active Pending
- 2024-01-11 WO PCT/US2024/011203 patent/WO2024151833A1/en not_active Ceased
- 2024-01-11 KR KR1020257026374A patent/KR20250133755A/en active Pending
-
2025
- 2025-06-22 IL IL321657A patent/IL321657A/en unknown
- 2025-07-07 MX MX2025007982A patent/MX2025007982A/en unknown
- 2025-08-05 CO CONC2025/0010728A patent/CO2025010728A2/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| MX2025007982A (en) | 2025-10-01 |
| KR20250133755A (en) | 2025-09-08 |
| IL321657A (en) | 2025-08-01 |
| CO2025010728A2 (en) | 2025-09-08 |
| CN120641409A (en) | 2025-09-12 |
| WO2024151833A1 (en) | 2024-07-18 |
| EP4649077A1 (en) | 2025-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP4342891A4 (en) | Spiro compound and use thereof | |
| CA3261302A1 (en) | Heterocycle rbm39 modulators | |
| AU2021382769A9 (en) | Dihydroisoquinolinone and isoindolinone derivatives and uses thereof | |
| EP4249481A4 (en) | Dihydroisoquinolinone and isoindolinone derivatives and uses thereof | |
| CA3278179A1 (en) | Spiro derivatives as m4 activators/modulators and uses thereof | |
| AU2024208125A1 (en) | Spiro derivatives as m4 activators/modulators and uses thereof | |
| EP4308558A4 (en) | Modulators of fpr1 and methods of using the same | |
| EP4136181A4 (en) | Adhesive article with strippable liner | |
| CA3265958A1 (en) | M4 activators/modulators and uses thereof | |
| AU2024206314A1 (en) | Gpr35 modulators | |
| EP4313042A4 (en) | Novel cyclopenta[c]pyrrol negative allosteric modulators of nr2b | |
| AU2025204768C1 (en) | Mtorc1 modulators and uses thereof | |
| CA3294797A1 (en) | Sestrin-mapk complex activators | |
| HK40125877A (en) | Compounds and their use as pde4 activators | |
| HK40067732A (en) | Macrocyclic azolopyridine derivatives as eed and prc2 modulators | |
| CA3285536A1 (en) | Kras modulators and uses thereof | |
| HK40118270A (en) | Kras modulators and uses thereof | |
| CA3271150A1 (en) | Substituted phenylbenzenesulfonamide derivatives and uses thereof | |
| HK40105639A (en) | Kinase modulators, compositions comprising the kinase modulator, and methods of using the same | |
| HK40089774A (en) | N-acetylserotonin derivatives as trkb activators and uses thereof | |
| CA3288123A1 (en) | Semi-saturated bicyclic derivatives and related uses | |
| HK40102971A (en) | Cbl-b modulators and uses thereof | |
| HK40103410A (en) | Cbl-b modulators and uses thereof | |
| CA3288983A1 (en) | Nk3 modulators and uses thereof | |
| HK40120400A (en) | Bicyclic-heterocycle derivatives and related uses |